TRDA Cash-Secured Put Strategy

TRDA (Entrada Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

TRDA (Entrada Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $284.2M, a beta of -0.09 versus the broader market, a 52-week range of 4.93-16.45, average daily share volume of 305K, a public-listing history dating back to 2021, approximately 183 full-time employees. These structural characteristics shape how TRDA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of -0.09 indicates TRDA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a cash-secured put on TRDA?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current TRDA snapshot

As of May 15, 2026, spot at $6.39, ATM IV 98.20%, IV rank 10.65%, expected move 28.15%. The cash-secured put on TRDA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this cash-secured put structure on TRDA specifically: TRDA IV at 98.20% is on the cheap side of its 1-year range, which means a premium-selling TRDA cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 28.15% (roughly $1.80 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TRDA expiries trade a higher absolute premium for lower per-day decay. Position sizing on TRDA should anchor to the underlying notional of $6.39 per share and to the trader's directional view on TRDA stock.

TRDA cash-secured put setup

The TRDA cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TRDA near $6.39, the first option leg uses a $6.07 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TRDA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TRDA shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$6.07N/A

TRDA cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

TRDA cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on TRDA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on TRDA

Cash-secured puts on TRDA earn premium while a trader waits to acquire TRDA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning TRDA.

TRDA thesis for this cash-secured put

The market-implied 1-standard-deviation range for TRDA extends from approximately $4.59 on the downside to $8.19 on the upside. A TRDA cash-secured put lets a trader earn premium while waiting to acquire TRDA at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current TRDA IV rank near 10.65% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TRDA at 98.20%. As a Healthcare name, TRDA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TRDA-specific events.

TRDA cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TRDA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TRDA alongside the broader basket even when TRDA-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on TRDA carry tail risk when realized volatility exceeds the implied move; review historical TRDA earnings reactions and macro stress periods before sizing. Always rebuild the position from current TRDA chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on TRDA?
A cash-secured put on TRDA is the cash-secured put strategy applied to TRDA (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With TRDA stock trading near $6.39, the strikes shown on this page are snapped to the nearest listed TRDA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are TRDA cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the TRDA cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 98.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a TRDA cash-secured put?
The breakeven for the TRDA cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TRDA market-implied 1-standard-deviation expected move is approximately 28.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on TRDA?
Cash-secured puts on TRDA earn premium while a trader waits to acquire TRDA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning TRDA.
How does current TRDA implied volatility affect this cash-secured put?
TRDA ATM IV is at 98.20% with IV rank near 10.65%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related TRDA analysis